Munich, Germany

Monika Baehner

This inventor holds 13 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monika Baehner. Retrieved from https://idiyas.com/inventor/monika-baehner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 69.2

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 242(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Monoclonal Antibodies
Bispecific Antibodies
Polypeptide Separation
VEGF
ANG-2
TWEAK
Antibody Variants
Lipid Particles
Tetranectin
Apolipoprotein A-I
13 patents (USPTO):Explore Patents

Title: Monika Baehner: Innovator in Polypeptide Separation Technologies

Introduction

Monika Baehner is a distinguished inventor based in Munich, Germany. She has made significant contributions to the field of biochemistry, particularly in the area of polypeptide separation technologies. With a total of 13 patents to her name, her work has had a profound impact on the industry.

Latest Patents

One of her latest patents is a method for the separation of monomeric polypeptides from aggregated polypeptides. This innovative method involves several steps: first, providing a solution that contains both monomeric and aggregated forms of the polypeptide, with a ratio of 4:1 or less as determined by size exclusion chromatography. Next, she employs mixed-mode chromatography in bind-and-elute mode, hydrophobic interaction chromatography in flow-through mode, or size-exclusion chromatography. Finally, a weak cation exchange chromatography is performed in either bind-and-elute mode or flow-through mode, resulting in the successful isolation of the polypeptide in its monomeric form.

Career Highlights

Throughout her career, Monika has worked with prominent companies such as Hoffmann-La Roche Inc. and Roche Glycart AG. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in her field.

Collaborations

Monika has collaborated with notable colleagues, including Sabine Imhof-Jung and Anita Kavlie. These partnerships have further enhanced her research and innovation capabilities.

Conclusion

Monika Baehner is a remarkable inventor whose work in polypeptide separation technologies continues to influence the biochemistry landscape. Her innovative methods and collaborations highlight her commitment to advancing scientific knowledge and practical applications in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…